HRMY - Harmony Bio falls as Goldman Sachs cuts to Sell on revenue risks
2023-09-25 13:08:43 ET
More on Harmony Bio
- Seeking Alpha’s Quant Rating on Harmony Biosciences
- Financial information for Harmony Biosciences
- Harmony Biosciences: A Balancing Act As Investors Lose Some Sleep
- Harmony Biosciences Holdings, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Harmony Biosciences: Rare Low-Volume Accumulation With Short Squeeze Potential
For further details see:
Harmony Bio falls as Goldman Sachs cuts to Sell on revenue risks